Lumakras 320 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DB25FKD45
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,492
Award facts
- Contract value 100% obligated
- $13,491.97 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 28, 2025, for the supply of Lumakras 320 mg tablets (90-count units) with a contract ceiling value of $13,491.97. The award is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 20, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a substantial $999,999,999.00 value through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement across the Defense Health Agency and military healthcare systems. The company's SPE2DX IDC functions as a comprehensive global pharmaceutical support vehicle, enabling delivery of specialty medications, brand-name and generic drugs, vaccines, and related medical supplies to support military healthcare programs worldwide. The current delivery order for Lumakras—an oncology medication—exemplifies the breadth of therapeutic products AmerisourceBergen supplies through its federal contract portfolio, which demonstrates the company's capability to fulfill specialized pharmaceutical requirements across multiple therapeutic domains through competitive federal procurement processes.
Quick answers
Who was awarded contract SPE2DB25FKD45?
SPE2DB25FKD45 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 28, 2025.
How much is contract SPE2DB25FKD45 worth?
The government has obligated $13,492 on SPE2DB25FKD45.
Is contract SPE2DB25FKD45 an order under another contract?
Yes. SPE2DB25FKD45 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FKD45 competed?
The extent of competition for SPE2DB25FKD45 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award